---
figid: PMC4666504__nihms-739406-f0007
figtitle: Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic
  pathway and increases low-density lipoprotein uptake
organisms:
- Mus musculus
- Rattus norvegicus
- Oryctolagus cuniculus
- Equus caballus
- Homo sapiens
- Armoracia rusticana
- Clinitrachus argentatus
organisms_ner:
- Oryctolagus cuniculus
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Equus caballus
- Drosophila melanogaster
pmcid: PMC4666504
filename: nihms-739406-f0007.jpg
figlink: /pmc/articles/PMC4666504/figure/F7/
number: F7
caption: NRG1 activates ERBB4 and induces proteolytic cleavage and release of membrane-
  anchored and soluble forms of the ICD. FL and ICD ERBB4 contribute to SREBP-2 activation
  through PI3K signaling pathways and, hypothetically, through direct interactions.
  ERBB4 enhances SREBP-2 cleavage through ERBB kinase activity but independent of
  AKT and mTORC1 resulting in increased expression of cholesterogenic genes (including
  HMGCR, HMGCS1, and LDLR) and increased LDL uptake and cholesterol synthesis. EGFR
  regulates fatty acid synthesis and increases LDLR expression through SREBP-1 (-),
  so activated EGFR might also regulate cholesterogenesis in parallel with ERBB4.
papertitle: Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic
  pathway and increases low-density lipoprotein uptake.
reftext: Jonathan W. Haskins, et al. Sci Signal. ;8(401):ra111-ra111.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9767128
figid_alias: PMC4666504__F7
figtype: Figure
redirect_from: /figures/PMC4666504__F7
ndex: 44ac87b8-deac-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4666504__nihms-739406-f0007.html
  '@type': Dataset
  description: NRG1 activates ERBB4 and induces proteolytic cleavage and release of
    membrane- anchored and soluble forms of the ICD. FL and ICD ERBB4 contribute to
    SREBP-2 activation through PI3K signaling pathways and, hypothetically, through
    direct interactions. ERBB4 enhances SREBP-2 cleavage through ERBB kinase activity
    but independent of AKT and mTORC1 resulting in increased expression of cholesterogenic
    genes (including HMGCR, HMGCS1, and LDLR) and increased LDL uptake and cholesterol
    synthesis. EGFR regulates fatty acid synthesis and increases LDLR expression through
    SREBP-1 (-), so activated EGFR might also regulate cholesterogenesis in parallel
    with ERBB4.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - NRG1
  - EGFR
  - ERBB4
  - SREBF2
  - SREBP-1
  - GNPTAB
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - AKT1
  - AKT2
  - AKT3
  - SREBF1
  - Egf
  - Nrg1
  - Egfr
  - Erbb4
  - Pik3cg
  - Akt1
  - Srebf2
  - Srebf1
  - Pik3r1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - SREBP
  - Cholesterol
  - Fatty Acid
---
